|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 232.35 USD | -2.49% |
|
-3.77% | +36.68% |
| 09-21 | Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on | RE |
| 09-16 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 15.08B 13.3B 12.58B 11.4B 21.4B 1,448B 21.6B 150B 58.03B 739B 56.63B 55.4B 2,373B | P/E 2026 * |
16x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 16.92B 14.92B 14.12B 12.79B 24.01B 1,624B 24.23B 169B 65.09B 829B 63.53B 62.14B 2,662B | EV / Sales 2026 * |
3.59x | EV / Sales 2027 * | 2.96x |
| Free-Float |
96.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Tradegate
| J7Z | Real-time | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote | |
|
Xetra
| J7Z | Delayed |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -2.49% | ||
| 1 week | -3.77% | ||
| Current month | -7.31% | ||
| 1 month | -4.98% | ||
| 3 months | +1.01% | ||
| 6 months | +27.18% | ||
| Current year | +36.68% |
| 1 week | 229.16 |  | 241.32 |
| 1 month | 229.16 | | 252.72 |
| Current year | 156.95 | | 266.38 |
| 1 year | 128.49 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Sell | General Counsel | -1,200 | 0.0018% | ||
| 9/8/26 | Tax | Chief Executive Officer | -3,967 | 0.0061% | ||
| 9/8/26 | Tax | Chief Technology Officer | -1,427 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.49% | -3.77% | +82.95% | +77.33% | 15.47B | |
| -0.01% | +1.69% | +63.50% | +117.58% | 1,056B | |
| -1.61% | -0.71% | +48.89% | +70.56% | 655B | |
| -1.12% | -0.45% | +19.35% | +72.93% | 471B | |
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | |
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +7.75% | +55.19% | +56.43% | 226B | |
| -0.61% | +0.48% | +34.95% | +100.58% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| Average | -0.74% | +0.36% | +35.07% | +51.59% | 365.84B | |
| Weighted average by Cap. | -0.63% | +0.75% | +40.03% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.16B 3.94B 3.57B 6.69B 453B 6.75B 47.05B 18.15B 231B 17.71B 17.32B 742B | 4.99B 4.4B 4.17B 3.78B 7.09B 479B 7.15B 49.81B 19.21B 245B 18.75B 18.34B 786B |
| Net income | 1B 886M 838M 760M 1.43B 96.44B 1.44B 10.02B 3.87B 49.24B 3.77B 3.69B 158B | 1.14B 1.01B 953M 863M 1.62B 110B 1.63B 11.39B 4.39B 55.94B 4.29B 4.19B 180B |
| Net Debt | 1.84B 1.62B 1.53B 1.39B 2.61B 176B 2.63B 18.32B 7.07B 90.01B 6.9B 6.75B 289B | -277M -245M -231M -210M -394M -26.63B -397M -2.77B -1.07B -13.59B -1.04B -1.02B -43.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$232.35 | -2.49% | 776,756 |
| 26-09-28 | US$238.28 | +0.14% | 788,284 |
| 26-09-25 | US$237.95 | +0.71% | 1,129,594 |
| 26-09-24 | US$236.28 | +0.60% | 551,318 |
| 26-09-23 | US$234.88 | -2.37% | 792,218 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
